Prenetics CIRCLE
Those wanting affordable multi-cancer screening
Test Performance
Sensitivity
Variable
Specificity
Variable
Detection Method
Whole-exome sequencing (germline DNA)
Turnaround
18 business days
Key Features
Direct to consumer • 5 cancer types • Affordable multi-cancer • Global availability
Who It's For
Important Notes
IMPORTANT:this is a hereditary risk test, not active cancer detection. CircleDNA is a consumer whole-exome saliva test whose Cancer Screening Report assesses inherited predisposition across 35+ cancers - it does not detect existing cancer. Hong Kong based (Prenetics Global, NASDAQ:PRE);pricing is served in HKD and varies by region. Prenetics'actual blood-based multi-cancer test is Presight, via the Insighta joint venture with Prof. Dennis Lo (lung and liver today;Presight One for 10+ cancers targeted for 2027).
Learn more about Prenetics CIRCLE
Discuss with your physician before ordering.
Visit Prenetics CIRCLECompare All